SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-052012
Filing Date
2018-08-14
Accepted
2018-08-14 17:17:43
Documents
69
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14116_110q.htm 10-Q 769771
2 EX-31.1 a18-14116_1ex31d1.htm EX-31.1 10075
3 EX-31.2 a18-14116_1ex31d2.htm EX-31.2 10074
4 EX-32.1 a18-14116_1ex32d1.htm EX-32.1 5223
5 EX-32.2 a18-14116_1ex32d2.htm EX-32.2 5195
  Complete submission text file 0001104659-18-052012.txt   4805881

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctrv-20180630.xml EX-101.INS 935988
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20180630.xsd EX-101.SCH 51712
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20180630_cal.xml EX-101.CAL 31186
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20180630_def.xml EX-101.DEF 220241
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20180630_lab.xml EX-101.LAB 465862
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20180630_pre.xml EX-101.PRE 355611
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 181018885
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1